Allergan Product-Hopping Suit Nixed On Faulty Assignments
A Delaware federal judge on Wednesday dismissed a product-hopping suit against Allergan Inc. over eye care products Zymar and Zymaxid after concluding the pharmacy chain that brought the putative class action...To view the full article, register now.
Already a subscriber? Click here to view full article